Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of Chronic Hepatitis B Virus Infection in Sierra Leone, 1997-2022: A Systematic Review and Meta-Analysis.
Yendewa GA, Wang GM, James PB, Massaquoi SPE, Yendewa SA, Ghazawi M, Babawo LS, Ocama P, Russell JBW, Deen GF, Sahr F, Kabba M, Tatsuoka C, Lakoh S, Salata RA. Yendewa GA, et al. Among authors: yendewa sa. Am J Trop Med Hyg. 2023 May 22;109(1):105-114. doi: 10.4269/ajtmh.22-0711. Print 2023 Jul 5. Am J Trop Med Hyg. 2023. PMID: 37217165 Free PMC article.
DISC: Describing Infections of the Spine treated with Ceftaroline.
Watkins RR, Yendewa G, Burdette SD, Horattas S, Haller NA, Mangira C, Salata RA, Bonomo RA. Watkins RR, et al. J Glob Antimicrob Resist. 2018 Jun;13:146-151. doi: 10.1016/j.jgar.2018.01.001. Epub 2018 Jan 11. J Glob Antimicrob Resist. 2018. PMID: 29337085
HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic.
Yendewa GA, Poveda E, Yendewa SA, Sahr F, Quiñones-Mateu ME, Salata RA. Yendewa GA, et al. Among authors: yendewa sa. AIDS Rev. 2018 Apr-Jun;20(2):104-113. doi: 10.24875/AIDSRev.M18000022. AIDS Rev. 2018. PMID: 29938704 Review.
A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation.
Yendewa GA, Griffiss JM, Jacobs MR, Fulton SA, O'Riordan MA, Gray WA, Proskin HM, Winkle P, Salata RA. Yendewa GA, et al. J Glob Antimicrob Resist. 2020 Jun;21:171-180. doi: 10.1016/j.jgar.2019.09.017. Epub 2019 Oct 7. J Glob Antimicrob Resist. 2020. PMID: 31600598 Free PMC article. Clinical Trial.
51 results